DrugPatentWatch Database Preview
Drugs in Development Information for Sirna-027
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Sirna-027?
Sirna-027 is an investigational drug.
There have been 22 clinical trials for Sirna-027.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.
The most common disease conditions in clinical trials are Pancreatic Neoplasms, Pachyonychia Congenita, and Nails, Malformed. The leading clinical trial sponsors are National Cancer Institute (NCI), Dicerna Pharmaceuticals, Inc., and Nitto Denko Corporation.
There are three US patents protecting this investigational drug and two hundred and fifty-five international patents.
Summary for Sirna-027
| US Patents | 3 |
| International Patents | 255 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-01-01) |
| Vendors | 0 |
Recent Clinical Trials for Sirna-027
| Title | Sponsor | Phase |
|---|---|---|
| iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation | National Cancer Institute (NCI) | Phase 1 |
| iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation | M.D. Anderson Cancer Center | Phase 1 |
| Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
Clinical Trial Summary for Sirna-027
Top disease conditions for Sirna-027
Top clinical trial sponsors for Sirna-027
US Patents for Sirna-027
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Sirna-027 | Start Trial | Recombinant vectors | Tocagen Inc. (San Diego, CA) | Start Trial |
| Sirna-027 | Start Trial | Compositions and methods to control angiogenesis with cupredoxins | The Board of Trustees of the University of Illinois (Urbana, IL) | Start Trial |
| Sirna-027 | Start Trial | Recombinant vectors | Tocagen Inc. (San Diego, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Sirna-027
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Sirna-027 | Australia | 2009303690 | 2028-09-26 | Start Trial |
| Sirna-027 | Brazil | PI0919113 | 2028-09-26 | Start Trial |
| Sirna-027 | Canada | 2738472 | 2028-09-26 | Start Trial |
| Sirna-027 | China | 102227501 | 2028-09-26 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
